CN107365340A - A kind of preparation method of the β diacetates of 3,5 estradiene 3,17 - Google Patents

A kind of preparation method of the β diacetates of 3,5 estradiene 3,17 Download PDF

Info

Publication number
CN107365340A
CN107365340A CN201710544016.2A CN201710544016A CN107365340A CN 107365340 A CN107365340 A CN 107365340A CN 201710544016 A CN201710544016 A CN 201710544016A CN 107365340 A CN107365340 A CN 107365340A
Authority
CN
China
Prior art keywords
estradienes
purity
diacetate
preparation
isopropanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710544016.2A
Other languages
Chinese (zh)
Inventor
张谦
乐强
肖祯
李栋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hubei University of Technology
Original Assignee
Hubei University of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hubei University of Technology filed Critical Hubei University of Technology
Priority to CN201710544016.2A priority Critical patent/CN107365340A/en
Publication of CN107365340A publication Critical patent/CN107365340A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0077Ethers

Abstract

The present invention relates to one kind 3,5 estradienes 3, the preparation method of 17 β diacetates, nandrolone, a hydration p-methyl benzenesulfonic acid, isopropyl acetate and No. 15 magnetons are sequentially added into reactor, heating response in oil bath pan after logical condensed water, when system starts condensing reflux, isopropenyl acetate is slowly injected into;After reaction terminates, solvent is steamed;System cooling plus pyridine, are added dropwise isopropanol, white solid product precipitation to be had;Sub-cooled filters, and is cleaned with cold isopropanol;White solid product is collected, the β diacetate net products of 3,5 estradiene 3,17 are produced after drying.The present invention carries out carbonyl using one pot synthesis as substrate using nandrolone and acetylating hydroxyl groups are protected, sintetics;Technique is simple, mild condition, yield up to 85%, it is environmentally friendly.The product of synthesis has important application value in medicine, veterinary drug and pesticide field;It is the important as precursors medicine of Tibolone.

Description

A kind of preparation method of -3,17 β of 3,5- estradienes-diacetate
Technical field
The present invention relates to a kind of synthesis of -3,17 β of 3,5- estradienes-diacetate class steroid drugs
Background technology
Steroid drugs plays a significant role in terms of disease preventing and treating, including medicine, veterinary drug and agricultural chemicals, what foreign countries had listed Steroidal drug has a kind more than 400, the existing kind in China only account for thirdly point one, also have very big gap from advanced international standard, In terms of steroid drugs research and development compared with advanced country in the world also a certain distance, be mainly shown as that steroid drugs synthesizes Step is more, and reaction is complicated, and the distant effect of group is fairly obvious, and yield is low, particularly isolates and purifies difficulty.Many steroid drugs The research of steroid drugs particularly with high content of technology goes to research and develop in China or blank, urgent need.
Steroid drugs Tibolone is the medicine that Dutch Ou Jianong (Organon) companies research and produce in the sixties in last century, It is used to treat osteoporosis earliest.Because it has weak estrogen, progestational hormone sample activity.It can make the inferior colliculus of climacteric women Pituitary system is stable, can substantially suppress blood plasma follicle-stimulating hormone (FSH) level.It is lighter to the inhibition level of metakentrin, do not influence The women of child-bearing age are had suppression Effect of Ovulation by prolactin(PRL, hormone replacement therapy (HRT) medicine are approved as quickly, for alleviating Menopause symptom after postmenopausal women.Organon companies in 1988 list in Holland first, in more than 80 country's listings.I State 60 one full year of life above women up to more than 70,000,000, into climacteric women more than 100,000,000 people.Steroid drugs Tibolone is mended with it Fill estrogen and eliminate climacteric syndrome shape, prevent from losing the sad outstanding advantages without causing uterus canceration and breast canceration, into To improve the choice drug of climacteric women quality of life.- 3,17 β of 3,5- estradienes-diacetate is steroid drugs for vigorous The important as precursors medicine of dragon, the synthesis of the medicine is a committed step.
The content of the invention
The purpose of the present invention is to be directed to above-mentioned present situation, it is desirable to provide a kind of technical process is simple, mild condition, and yield is high - 3,17 β of 3,5- estradienes-diacetate preparation method.
The implementation of the object of the invention is the preparation method of one kind 3,5- estradienes -3,17 β-diacetate, by elder generation Order adds 4.8g nandrolones, 168mg a hydration p-methyl benzenesulfonic acid, 6.2mL isopropyl acetate into 250mL double-neck flasks afterwards With No. 15 magnetons, after spherical condensation tube is led into condensed water from the bottom to top, reactor is placed in heating response in 120 DEG C of oil bath pans; When system starts condensing reflux, 6.4mL isopropenyl acetates are slowly injected into reaction system with syringe, it is every with TLC Detect and react every 30min;After reaction terminates, it is distilling apparatus to change condensation reflux unit, and 4.8mL solvents are steamed from reactor; After distillation terminates, temperature of reaction system is down to 75-80 DEG C, 16.4mL pyridine is added to system;Again by temperature of reaction system 75 DEG C are down to, 9.6mL isopropanol is then added dropwise, has white solid product precipitation;After the completion of feeding intake, by reaction system - 15 DEG C to -5 DEG C are cooled to, is then filtered with 500mL Buchner funnel, with cold 0 DEG C to 5 DEG C isopropanol wash products, cleaning Twice, each 50mL;White solid product is collected, in vacuum drying chamber, after 50-60 DEG C of dry 2h, produces 3,5- female steroids two The β of alkene-3,17-diacetate net product.
The present invention carries out carbonyl using one pot synthesis as substrate using nandrolone and acetylating hydroxyl groups are protected, 3,5- of synthesis female steroids two The β of alkene-3,17-diacetate;Technique is simple, mild condition, yield up to 85%, it is environmentally friendly.The 3,5- estradienes of synthesis- 3,17 β-diacetate class steroid drugs has important application value in medicine, veterinary drug and pesticide field.The 3 of gained of the invention, - 3,17 β of 5- estradienes-diacetate is the important as precursors medicine of Tibolone.
Embodiment
Sequentially addition nandrolone, a hydration p-methyl benzenesulfonic acid, isopropyl acetate and No. 15 into reactor of the invention Magneton, lead to after condensed water heating response in oil bath pan, when system starts condensing reflux, be slowly injected into isopropenyl acetate; After reaction terminates, solvent is steamed;System cooling plus pyridine, are added dropwise isopropanol, white solid product precipitation to be had;Sub-cooled is taken out Filter, is cleaned with cold isopropanol;White solid product is collected, it is pure to produce 3,5- estradienes -3,17 β-diacetate after drying Product.Reaction expression is
Spherical condensation tube leads to after condensed water from the bottom to top is placed in heating response in 120 DEG C of oil bath pans by double-neck flask, is double Neck flask bottom is immersed in silicone oil, and submergence is silicone oil highly higher than reaction solution height in double-neck flask.
The purity of nandrolone used is 98%, and the purity of a hydration p-methyl benzenesulfonic acid is 99%, and isopropyl acetate purity is 99%, the purity of isopropenyl acetate is 99%, and the purity of pyridine is 99.5%, and the purity of isopropanol is 99.7%.
Isopropenyl acetate is slowly injected into reaction system with syringe, is detected and reacted every 30min with TLC.15 Number magneton, magnetic stirring apparatus rotating speed is 500 turns/s.
The present invention is described in detail with specific embodiment below.
4.8g nandrolones, 168mg a hydration p-methyl benzenesulfonic acid, 6.2mL are sequentially added into 250mL double-neck flasks Isopropyl acetate and No. 15 magnetons, will spherical condensation tube lead to condensed water from the bottom to top after reactor is placed in 120 DEG C of oil bath pans Middle heating response.When system starts condensing reflux, 6.4mL isopropenyl acetic acid is slowly injected into reaction system with syringe Ester, detected and reacted every 30min with TLC.After reaction terminates, it is distilling apparatus to change condensation reflux unit, is steamed from reactor 4.8mL solvent (equivalent to the inlet amount of nandrolone);After distillation terminates, temperature of reaction system is down to 75-80 DEG C, in humidity province Between 16.4mL pyridine is added in scope to system.Temperature of reaction system is down to 75 DEG C again, the different of 9.6mL is then added dropwise Propyl alcohol, have white solid product precipitation.After the completion of feeding intake, reaction system is cooled to -15 DEG C to -5 DEG C, then uses 500mL Buchner funnel filter, with cold 0 DEG C to 5 DEG C isopropanol wash products, cleaning twice, each 50mL;Collect white solid production Thing, in vacuum drying chamber after 50-60 DEG C of dry 2h, 3,5- estradienes -3,17 β-diacetate net product is produced, yield is 85%.
Hydrogen nuclear magnetic resonance1H NMR(400MHz,CDCl3):δ0.82(s,3H),0.90–0.99(m,1H),1.07–1.16 (m,1H),1.18–1.28(m,3H),1.31–1.38(m,1H),1.43–1.56(m,2H),1.60–1.73(m,2H),1.76– 1.78(m,1H),1.86–1.92(m,2H),2.04(s,3H),2.07–2.11(m,1H),2.13(s,3H),2.15–2.22(m, 3H), 2.43-2.49 (m, 1H), 4.62 (t, J=8.44Hz, 1H), 5.47 (s, 1H), 5.76-5.77 (m, 1H);13C NMR (100MHz,CDCl3):δ11.9,21.1,21.2,23.3,26.2,27.2,27.5,28.0,30.9,36.6,36.6,40.6, 42.6,43.5,50.3,82.8,117.6,123.7,134.6,148.7,169.2,171.2。

Claims (4)

1. one kind 3, the preparation method of 5- estradienes -3,17 β-diacetate, it is characterised in that:Sequentially to 250mL 4.8g nandrolones, 168mg a hydration p-methyl benzenesulfonic acid, 6.2mL isopropyl acetate and No. 15 magnetons are added in double-neck flask, will After spherical condensation tube leads to condensed water from the bottom to top, reactor is placed in heating response in 120 DEG C of oil bath pans;When system starts to condense During backflow, 6.4mL isopropenyl acetates are slowly injected into reaction system with syringe, are detected instead every 30min with TLC Should;After reaction terminates, it is distilling apparatus to change condensation reflux unit, and 4.8mL solvents are steamed from reactor;, will after distillation terminates Temperature of reaction system is down to 75-80 DEG C, and 16.4mL pyridine is added to system;Temperature of reaction system is down to 75 DEG C again, then 9.6mL isopropanol is added dropwise, has white solid product precipitation;After the completion of feeding intake, reaction system is cooled to -15 DEG C To -5 DEG C, then filtered with 500mL Buchner funnel, with cold 0 DEG C to 5 DEG C isopropanol wash products, cleaned twice, every time 50mL;Collect white solid product, in vacuum drying chamber, after 50-60 DEG C of dry 2h, produce 3,5- estradienes -3,17 β - Diacetate net product.
2. a kind of preparation method of 3,5- estradienes -3,17 β-diacetate according to claim 1, its feature exist In:Double-neck flask bottom is immersed in silicone oil, and submergence is silicone oil highly higher than reaction solution height in double-neck flask.
3. a kind of preparation method of 3,5- estradienes -3,17 β-diacetate according to claim 1, its feature exist In:The purity of nandrolone is 98%, and the purity of a hydration p-methyl benzenesulfonic acid is 99%, and isopropyl acetate purity is 99%, isopropyl alkene The purity of base acetate is 99%, and the purity of pyridine is 99.5%, and the purity of isopropanol is 99.7%.
4. a kind of preparation method of 3,5- estradienes -3,17 β-diacetate according to claim 1, its feature exist In:No. 15 magnetons, magnetic stirring apparatus rotating speed are 500 turns/s.
CN201710544016.2A 2017-07-05 2017-07-05 A kind of preparation method of the β diacetates of 3,5 estradiene 3,17 Pending CN107365340A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710544016.2A CN107365340A (en) 2017-07-05 2017-07-05 A kind of preparation method of the β diacetates of 3,5 estradiene 3,17

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710544016.2A CN107365340A (en) 2017-07-05 2017-07-05 A kind of preparation method of the β diacetates of 3,5 estradiene 3,17

Publications (1)

Publication Number Publication Date
CN107365340A true CN107365340A (en) 2017-11-21

Family

ID=60305923

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710544016.2A Pending CN107365340A (en) 2017-07-05 2017-07-05 A kind of preparation method of the β diacetates of 3,5 estradiene 3,17

Country Status (1)

Country Link
CN (1) CN107365340A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113045617A (en) * 2021-03-29 2021-06-29 湖北共同药业股份有限公司 Preparation method of 3, 5-estradiene-3, 17 beta-diacetate

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500669B1 (en) * 1994-05-04 2002-12-31 Massachusetts Institute Of Technology Programmable genotoxic agents and uses therefor
CN1780849A (en) * 2003-03-04 2006-05-31 雷索卢蒂恩化学品有限公司 Process for the production of tibolone
WO2015181116A1 (en) * 2014-05-26 2015-12-03 Crystal Pharma, S.A.U. Process and intermediades for the preparation of 7-alkylated steroids

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500669B1 (en) * 1994-05-04 2002-12-31 Massachusetts Institute Of Technology Programmable genotoxic agents and uses therefor
CN1780849A (en) * 2003-03-04 2006-05-31 雷索卢蒂恩化学品有限公司 Process for the production of tibolone
WO2015181116A1 (en) * 2014-05-26 2015-12-03 Crystal Pharma, S.A.U. Process and intermediades for the preparation of 7-alkylated steroids

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113045617A (en) * 2021-03-29 2021-06-29 湖北共同药业股份有限公司 Preparation method of 3, 5-estradiene-3, 17 beta-diacetate
CN113045617B (en) * 2021-03-29 2023-11-24 湖北共同药业股份有限公司 Preparation method of 3, 5-estradiene-3, 17 beta-diacetate

Similar Documents

Publication Publication Date Title
CN109776644B (en) Synthesis method of progesterone
CN106866766A (en) The preparation method and preparation system of a kind of medroxyprogesterone acetate
CN107365340A (en) A kind of preparation method of the β diacetates of 3,5 estradiene 3,17
US3257278A (en) 13beta-alkyl-delta-4, 9, 11-gonatriene-3-ones
CN107200762A (en) The preparation method of the β diacetates of 3,5 estradiene 3,17
CN100378055C (en) One-step prepn process of acid gossypol derivative with acid and acetone aqua
CN109232700A (en) A kind of high-efficiency synthesis method of Altrenogest
Nenitzescu et al. The synthesis of cyclic alcohols and olefins by the interaction of dimagnesium halides and esters
CN100422204C (en) 7-keto deoxy epiandrosterone and its acetate synthesizing method
CN115872948B (en) Crystal form B of ritodrine, and preparation method and application thereof
CN105541951A (en) Method for refining obeticholic acid
CN102276426A (en) Novel synthetic method of 3, 4, 5-trihydroxystilbene
CN1117759C (en) Steroid and its preparation method, medicine composition and application
CN101434522B (en) Method for preparing high-purity gossypol from cottonseed dephenolizing solution
CN114195844A (en) Preparation method of dehydroepiandrosterone
CN1087090A (en) 17 replace 11 beta substitution aromatic bases-4, the complete synthesizing process of 9-estradiene compounds
CN107188916A (en) A kind of preparation method of 6 dehydrogenation nandrolone acetate
CN106542961B (en) A kind of synthetic method of racecadotril intermediate
CN110015948A (en) A method of synthesis high purity borneol
CN109369398A (en) A kind of maize alcohol stillage Content of Chlorogenic Acid purifying process
CN107098825A (en) A kind of high efficiency preparation method of fortimicin
CN107827941A (en) Rutin extraction method
CN113861141B (en) Preparation method of andrographolide sulfonate for controlling anaphylactic reaction of traditional Chinese medicine injection
US3313702A (en) Estrogenic compositions comprising 17alpha-ethynyl-deta1, 3, 5(10)-estratriene-3, 11beta, 17beta-triol
CN103012539B (en) The production method of ursodeoxycholic acid is produced with the ursodesoxycholic acid of content 98.5%

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20171121

WD01 Invention patent application deemed withdrawn after publication